| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 147,470 | 120,647 | 139,614 | 131,073 | | Cost of Revenue | 53,915 | 46,307 | 57,830 | 57,827 | | | Gross Profit | 93,555 | 74,340 | 81,784 | 73,246 | | | Operating Expenses | | Research Development | 436 | 478 | 486 | 1,295 | | Selling General and Administrative | 81,139 | 72,800 | 80,658 | 90,108 | | Non Recurring |
-
| 110 | 378 | 32,060 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,980 | 952 | 262 | (50,217) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,896) | (69) | 14 | 132 | | Earnings Before Interest And Taxes | 7,084 | 883 | 276 | (50,085) | | Interest Expense | (3,192) | 1,408 | 1,784 | 1,421 | | Income Before Tax | 10,276 | (525) | (1,508) | (51,506) | | Income Tax Expense | 3,377 | 3,436 | 1,187 | 5,930 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,899 | (3,961) | (2,695) | (57,436) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,899 | (3,961) | (2,695) | (57,436) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,899 | ($3,961) | ($2,695) | ($57,436) |
|
0.51% Nasdaq 
Income Statement
